To determine whether GA reduced MMP-2 and -9 expression at the transcriptional level, we evaluated MMP promoter activity by transfecting TSC cells with a MMP-2 or -9 promoter-luciferase reporter constructs and then treated with GA. This evidence concerns the gene MMP2 and tuberous sclerosis.